Medicus Pharma Ltd. (MDCX)
0.26
-0.01
(-4.34%)
USD |
NASDAQ |
Aug 24, 16:00
0.256
0.00 (0.00%)
After-Hours: 20:00
Medicus Pharma Total Assets (Quarterly) : 19.11M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.11M |
| March 31, 2026 | 5.322M |
| December 31, 2025 | 7.340M |
| September 30, 2025 | 7.171M |
| June 30, 2025 | 8.746M |
| March 31, 2025 | 5.658M |
| December 31, 2024 | 3.926M |
| September 30, 2024 | 4.235M |
| Date | Value |
|---|---|
| June 30, 2024 | 6.417M |
| March 31, 2024 | 0.728M |
| December 31, 2023 | 1.893M |
| September 30, 2023 | 5.108M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 0.2086M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 792.26M |
| enGene Therapeutics, Inc. | 307.52M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.296B |
| Psyence Biomedical Ltd. | 12.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.33M |
| Shareholders Equity (Quarterly) | -1.243M |
| Debt to Equity Ratio | -12.27 |
| Current Ratio | 1.566 |
| Net Debt Paydown Yield | -11.14% |